Chan WPW - Search Results

1

Clinical utility of thiopurine metabolite monitoring in inflammatory bowel disease and its impact on healthcare utilization in Singapore.

Yeo JQ, Cheen HHM, Wong A, Lim TG, Chowbay B, Leong WF, Wang C, Salazar E, Chan WPW, Kong SC, Ong WC. Yeo JQ, et al. Among authors: chan wpw. JGH Open. 2022 Aug 1;6(10):658-666. doi: 10.1002/jgh3.12798. eCollection 2022 Oct. JGH Open. 2022. PMID: 36262537 Free PMC article.

2

Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients.

Sutiman N, Chen S, Ling KL, Chuah SW, Leong WF, Nadiger V, Tjai M, Choon Kong CS, Schwender BJ, Chan W, Shim HH, Lim WC, Khor CC, Cheung YB, Chowbay B. Sutiman N, et al. Pharmacogenomics. 2018 Jan;19(1):31-43. doi: 10.2217/pgs-2017-0147. Epub 2017 Dec 6. Pharmacogenomics. 2018. PMID: 29210335 Free PMC article.

3

An intronic FTO variant rs16952570 confers protection against thiopurine-induced myelotoxicities in multiethnic Asian IBD patients.

Chen S, Tan WZ, Sutiman N, Lim C, Lee SS, Leong WF, Tjai M, Wang C, Kong CSC, Chuah SW, Schwender BJ, Chan W, Shim HH, Lim WC, Khor CC, Ling KL, Chowbay B. Chen S, et al. Pharmacogenomics J. 2020 Jun;20(3):505-515. doi: 10.1038/s41397-019-0126-9. Epub 2019 Dec 9. Pharmacogenomics J. 2020. PMID: 31813937

4

Vaccinations and inflammatory bowel disease - a systematic review.

Chan W, Salazar E, Lim TG, Ong WC, Shim HH. Chan W, et al. Dig Liver Dis. 2021 Sep;53(9):1079-1088. doi: 10.1016/j.dld.2021.04.015. Epub 2021 May 11. Dig Liver Dis. 2021. PMID: 33994128

5

Favorable vaccine-induced SARS-CoV-2-specific T cell response profile in patients undergoing immune-modifying therapies.

Qui M, Le Bert N, Chan WPW, Tan M, Hang SK, Hariharaputran S, Sim JXY, Low JGH, Ng W, Wan WY, Ang TL, Bertoletti A, Salazar E. Qui M, et al. Among authors: chan wpw. J Clin Invest. 2022 Jun 15;132(12):e159500. doi: 10.1172/JCI159500. J Clin Invest. 2022. PMID: 35536644 Free PMC article.

6

A quality improvement project reduces time spent at an inflammatory bowel disease infusion center with accelerated infliximab infusion protocol.

Ong WC, Lim MS, Chan E, Lim TCT, Lim TG, Chan W. Ong WC, et al. JGH Open. 2022 Jun 1;6(7):470-476. doi: 10.1002/jgh3.12776. eCollection 2022 Jul. JGH Open. 2022. PMID: 35822121 Free PMC article.

7

Approximately 1 in 10 ambulatory inflammatory bowel disease patients are at risk of malnutrition: A prospective Singapore cohort.

Sim B, Cheah MCC, Chan WPW, Wang YT, Tan MTK, Shim HH, Salazar E. Sim B, et al. Among authors: chan wpw. J Dig Dis. 2023 Jan;24(1):10-18. doi: 10.1111/1751-2980.13165. J Dig Dis. 2023. PMID: 36951292

8

Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability.

Chan W, Shim HH, Lim MS, Sawadjaan FLB, Isaac SP, Chuah SW, Leong R, Kong C. Chan W, et al. Dig Liver Dis. 2017 Dec;49(12):1314-1319. doi: 10.1016/j.dld.2017.08.020. Epub 2017 Aug 14. Dig Liver Dis. 2017. PMID: 28882540

9

Crohn's disease associated strictures.

Chan WPW, Mourad F, Leong RW. Chan WPW, et al. J Gastroenterol Hepatol. 2018 May;33(5):998-1008. doi: 10.1111/jgh.14119. Epub 2018 Mar 12. J Gastroenterol Hepatol. 2018. PMID: 29427364 Review.

10

Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease.

Chan W, Lynch N, Bampton P, Chang J, Chung A, Florin T, Hetzel DJ, Jakobovits S, Moore G, Pavli P, Radford-Smith G, Thin L, Baraty B, Haifer C, Yau Y, Leong RWL. Chan W, et al. Eur J Gastroenterol Hepatol. 2018 Jul;30(7):735-740. doi: 10.1097/MEG.0000000000001150. Eur J Gastroenterol Hepatol. 2018. PMID: 29727386

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters